The narrative: screens emit blue light, blue light suppresses melatonin, therefore screens disrupt sleep. Each step is partially true, but the end-to-end effect is smaller than the $28 billion blue-light-blocking industry needs it to be. Dr. Timothy Brown (University of Manchester), whose 2019 Current Biology paper challenged the blue-light-is-worst model, puts it bluntly: the dose from a phone screen is orders of magnitude below what shifts the circadian clock in laboratory conditions.
Melanopsin, the photopigment in retinal ganglion cells discovered by Dr. Ignacio Provencio (University of Virginia) in 2000, is most sensitive to the 460-480 nm range. Exposure at sufficient intensity suppresses melatonin and shifts the circadian clock later. This is established photobiology, confirmed across hundreds of studies.
More representative studies tell a different story. A 2021 randomized controlled trial by Dr. Brit Saksvik-Lehouillier (NTNU, Norway, n=113) found blue-light-blocking glasses worn for three hours before bed did not significantly improve sleep quality, efficiency, or latency compared to clear-lens placebo glasses. A Cochrane-style review in Ophthalmic and Physiological Optics (2023, k=6) reached the same conclusion: insufficient evidence to recommend blue-light-filtering lenses for sleep improvement.
What may matter more is behavioral engagement. Dr. Heather Cleland Woods (University of Glasgow) found in a 2016 Journal of Youth Studies sample (n=467) that social media scrolling was associated with poorer sleep quality independent of light exposure. A 2023 Sleep Health study (n=58) by Dr. Chad Jensen (Brigham Young University) found that using a phone with Night Shift enabled was equally disruptive as using an unfiltered phone, strongly supporting the cognitive arousal hypothesis over the photobiological one.
Practical recommendation: Dr. Charles Czeisler (Harvard, chief of sleep medicine at Brigham and Women's) recommends stopping screen use 30-60 minutes before bed, dimming room lighting, and replacing scrolling with a low-stimulation activity. The behavioral change is more evidence-based than blue-light-blocking glasses, which a 2024 Cochrane review called "not supported by current evidence."